These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11759057)

  • 21. Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification.
    Brunelli M; Erdini F; Cima L; Eccher A; Fioravanzo A; Gobbo S; Segala D; Ghimenton C; Mazzoleni G; Munari E; Carella R; Martignoni G
    Appl Immunohistochem Mol Morphol; 2018; 26(5):316-323. PubMed ID: 27556823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms.
    Gonzalez-Roibon N; Faraj SF; Munari E; Bezerra SM; Albadine R; Sharma R; Argani P; Allaf ME; Netto GJ
    Hum Pathol; 2014 Feb; 45(2):244-8. PubMed ID: 24315206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.
    Taki A; Nakatani Y; Misugi K; Yao M; Nagashima Y
    Mod Pathol; 1999 Mar; 12(3):310-7. PubMed ID: 10102617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
    Geramizadeh B; Ravanshad M; Rahsaz M
    Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinoma.
    Kuroda N; Kanomata N; Yamaguchi T; Imamura Y; Ohe C; Sakaida N; Hes O; Michal M; Shuin T; Lee GH
    Med Mol Morphol; 2011 Jun; 44(2):111-5. PubMed ID: 21717314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
    Kruck S; Hennenlotter J; Vogel U; Schilling D; Gakis G; Hevler J; Kuehs U; Stenzl A; Schwentner C
    BJU Int; 2012 Feb; 109(4):634-8. PubMed ID: 21711439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression analysis of Wnt-5a in renal epithelial neoplasms: distinguishing renal oncocytoma from a wide spectrum of renal cell carcinomas.
    Rao Q; Liu XH; Zhou HB; Ma HH; Lu ZF; Zhou XJ
    Tumori; 2010; 96(2):304-9. PubMed ID: 20572590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleophosmin expression in renal cell carcinoma and oncocytoma.
    Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F
    APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J
    Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
    Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
    Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of heterochromatin protein 1α/β in the kidney tumors: a microarray immunohistochemical study.
    Han B; Ziober A; Lu S; Bing Z
    Ann Diagn Pathol; 2013 Apr; 17(2):172-5. PubMed ID: 23142018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ARPP protein is selectively expressed in renal oncocytoma, but rarely in renal cell carcinomas.
    Shomori K; Nagashima Y; Kuroda N; Honjo A; Tsukamoto Y; Tokuyasu N; Maeta N; Matsuura K; Hijiya N; Yano S; Yokoyama S; Ito H; Moriyama M
    Mod Pathol; 2007 Feb; 20(2):199-207. PubMed ID: 17206105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours.
    Cornelis F; Tricaud E; Lasserre AS; Petitpierre F; Bernhard JC; Le Bras Y; Yacoub M; Bouzgarrou M; Ravaud A; Grenier N
    Eur Radiol; 2014 May; 24(5):1068-80. PubMed ID: 24557052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of CK7, S100A1, and CD82 (KAI1) Expression in the Differential Diagnosis of Chromophobe Renal Cell Carcinoma and Renal Oncocytoma.
    Sari ZB; Açikalin MF; Arik D; Özen A; Can C; Çolak E
    Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):534-540. PubMed ID: 33605572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma.
    Wang HY; Mills SE
    Am J Surg Pathol; 2005 May; 29(5):640-6. PubMed ID: 15832088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions.
    Cao Y; Karsten U; Zerban H; Bannasch P
    Virchows Arch; 2000 Feb; 436(2):119-26. PubMed ID: 10755601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors.
    Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Genin C; Tostain J
    Cell Oncol; 2005; 27(1):51-6. PubMed ID: 15750207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of CD138 (Syndecan-1) in renal cell carcinoma is reduced with increasing nuclear grade.
    Gökden N; Greene GF; Bayer-Garner IB; Spencer HJ; Sanderson RD; Gökden M
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):173-7. PubMed ID: 16785785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.